Moreover, given the significant downregulation of ECM-1 in all ZSF1 groups and time-points studied in this inflammation assay, it is possible that targeting this gene may be helpful to overcome both hypertension and HFpEF (early and late) or hypertension alone (reported in both genotypes). The gene discussed is ECM1; the disease is hypertensive disorder.